Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yibei Xiao

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|May 3, 2025
Design, Synthesis, and Biological Evaluation of Novel Activators of Human Caseinolytic Protease P with a Pyrazololactam ScaffoldRui Tang, Qiannan Li, Heyang Zhou, et al.
Molecular Cell|April 13, 2019
Introducing a Spectrum of Long-Range Genomic Deletions in Human Embryonic Stem Cells Using Type I CRISPR-CasAdam E Dolan, Zhonggang Hou, Yibei Xiao, et al.
Cell Research|October 25, 2024
The mechanism of bacterial defense system DdmDE from Lactobacillus caseiPingping Huang, Purui Yan, Lijie Guo, et al.
Biochemical and Biophysical Research Communications|May 22, 2026
Structural and functional characterization of SPARTA systemHongze Zhao, Pingping Huang, Lijie Guo, et al.
Journal of Medicinal Chemistry|July 3, 2025
Discovery of SaClpP-Selective Imipridone Derivatives as Novel Antistaphylococcal AgentsJiajun Luo, Jie Yin, Guangjun Xie, et al.
Journal of Medicinal Chemistry|June 6, 2025
Correction to "Design, Synthesis, and Biological Evaluation of Novel Activators of Human Caseinolytic Protease P with a Pyrazololactam Scaffold"Rui Tang, Qiannan Li, Heyang Zhou, et al.
Journal of Medicinal Chemistry|June 16, 2025
Discovery and Crystallography Study of Novel Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer TreatmentZichao Yang, Pan Yang, Jianwei Xu, et al.
Journal of Medicinal Chemistry|November 30, 2023
Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate CancerKai Yuan, Fei Xia, Qiannan Li, et al.
Journal of Medicinal Chemistry|December 12, 2022
Structure-Based Design of a Dual-Targeted Covalent Inhibitor Against Papain-like and Main Proteases of SARS-CoV-2Wenying Yu, Yucheng Zhao, Hui Ye, et al.
Journal of Medicinal Chemistry|April 27, 2024
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S MutationYasheng Zhu, Xiuquan Ye, Yuxing Wu, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|May 3, 2025
Design, Synthesis, and Biological Evaluation of Novel Activators of Human Caseinolytic Protease P with a Pyrazololactam ScaffoldRui Tang, Qiannan Li, Heyang Zhou, et al.
Molecular Cell|April 13, 2019
Introducing a Spectrum of Long-Range Genomic Deletions in Human Embryonic Stem Cells Using Type I CRISPR-CasAdam E Dolan, Zhonggang Hou, Yibei Xiao, et al.
Cell Research|October 25, 2024
The mechanism of bacterial defense system DdmDE from Lactobacillus caseiPingping Huang, Purui Yan, Lijie Guo, et al.
Biochemical and Biophysical Research Communications|May 22, 2026
Structural and functional characterization of SPARTA systemHongze Zhao, Pingping Huang, Lijie Guo, et al.
Journal of Medicinal Chemistry|July 3, 2025
Discovery of SaClpP-Selective Imipridone Derivatives as Novel Antistaphylococcal AgentsJiajun Luo, Jie Yin, Guangjun Xie, et al.
Journal of Medicinal Chemistry|June 6, 2025
Correction to "Design, Synthesis, and Biological Evaluation of Novel Activators of Human Caseinolytic Protease P with a Pyrazololactam Scaffold"Rui Tang, Qiannan Li, Heyang Zhou, et al.
Journal of Medicinal Chemistry|June 16, 2025
Discovery and Crystallography Study of Novel Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer TreatmentZichao Yang, Pan Yang, Jianwei Xu, et al.
Journal of Medicinal Chemistry|November 30, 2023
Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate CancerKai Yuan, Fei Xia, Qiannan Li, et al.
Journal of Medicinal Chemistry|December 12, 2022
Structure-Based Design of a Dual-Targeted Covalent Inhibitor Against Papain-like and Main Proteases of SARS-CoV-2Wenying Yu, Yucheng Zhao, Hui Ye, et al.
Journal of Medicinal Chemistry|April 27, 2024
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S MutationYasheng Zhu, Xiuquan Ye, Yuxing Wu, et al.
Pageof 9